𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-α2b in patients with solid tumors

✍ Scribed by Bryan Schneider; Anna Fukunaga; Daryl Murry; Christy Yoder; Karen Fife; Anne Foster; Leslie Rosenberg; Stephanie Kelich; Lang Li; Christopher Sweeney

Publisher
Springer
Year
2006
Tongue
English
Weight
334 KB
Volume
59
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical trial of weekly combine
Phase I clinical trial of weekly combined paclitaxel plus docetaxel in patients with solid tumors
✍ Jacob Lokich 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

A Phase I and feasibility study of combined docetaxel (D) plus paclitaxel (P) was undertaken to determine the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) for each analogue delivered concomitantly on a weekly schedule. ## METHODS. Patients were accrued in 3-6 patient cohorts to P

Temozolomide in combination with interfe
Temozolomide in combination with interferon α-2b in patients with metastatic melanoma : A Phase I dose-escalation study
✍ Sanjiv S. Agarwala; John M. Kirkwood 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Abstract ## BACKGROUND Metastatic melanoma (MM) is associated with a high risk of central nervous system (CNS) metastases, and current chemotherapy does not adequately treat or protect patients with MM against CNS metastases. Therefore, the authors initiated a Phase I study to determine the pha